178 related articles for article (PubMed ID: 31183212)
1. Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.
Cho J; Chen JCY; Paludo J; Conboy EE; Lanpher BC; Alberts SR; Halfdanarson TR
J Gastrointest Oncol; 2019 Jun; 10(3):582-588. PubMed ID: 31183212
[TBL] [Abstract][Full Text] [Related]
2. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
[TBL] [Abstract][Full Text] [Related]
4. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
Surjan RCT; de Lima TM; de Souza HP; Machado MCC; Ardengh JC
Cureus; 2023 Jan; 15(1):e33750. PubMed ID: 36788919
[TBL] [Abstract][Full Text] [Related]
7. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
[TBL] [Abstract][Full Text] [Related]
8. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
9. Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma.
Alsina AE; Franco E; Nakshabandi A; Albers C; Kemmer N; Berry AC; Finan J
ACG Case Rep J; 2016 Aug; 3(4):e106. PubMed ID: 27807568
[TBL] [Abstract][Full Text] [Related]
10. Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.
Upadhyay R; Bleck TP; Busl KM
Case Rep Med; 2016; 2016():8512721. PubMed ID: 27738433
[No Abstract] [Full Text] [Related]
11. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.
Suarez O; Perez M; Garzon M; Daza R; Hernandez G; Salinas C; Ceballos J; de Leon EP; Mugnier J; Beltrán O; Varón A
Case Reports Hepatol; 2018; 2018():7521986. PubMed ID: 30631612
[TBL] [Abstract][Full Text] [Related]
12. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet.
Ben-Ari Z; Dalal A; Morry A; Pitlik S; Zinger P; Cohen J; Fattal I; Galili-Mosberg R; Tessler D; Baruch RG; Nuoffer JM; Largiader CR; Mandel H
J Hepatol; 2010 Feb; 52(2):292-5. PubMed ID: 20031247
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
Felig DM; Brusilow SW; Boyer JL
Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
[TBL] [Abstract][Full Text] [Related]
15. Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration.
Gascon-Bayarri J; Campdelacreu J; Estela J; Reñé R
Case Rep Neurol Med; 2015; 2015():453752. PubMed ID: 25949836
[TBL] [Abstract][Full Text] [Related]
16. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.
Eggert T; McGlynn KA; Duffy A; Manns MP; Greten TF; Altekruse SF
United European Gastroenterol J; 2013 Oct; 1(5):351-7. PubMed ID: 24917983
[TBL] [Abstract][Full Text] [Related]
17. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
[No Abstract] [Full Text] [Related]
18. Fibrolamellar hepatocellular carcinoma mimicking ornithine transcarbamylase deficiency.
Sulaiman RA; Geberhiwot T
JIMD Rep; 2014; 16():47-50. PubMed ID: 24997132
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy.
Hasegawa T; Tzakis AG; Todo S; Reyes J; Nour B; Finegold DN; Starzl TE
J Pediatr Surg; 1995 Jun; 30(6):863-5. PubMed ID: 7666324
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
Lee NR; Yhim HY; Yim CY; Kwak JY; Song EK
Ann Pharmacother; 2011 Oct; 45(10):e56. PubMed ID: 21954449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
